DDX5 and hepatocellular carcinoma: DDX5 promotes Stat1 mRNA translation and in turn, Stat1 mediates the IFN response in HCC cells and liver tumors, and DDX5KD reduced both Stat1 and the antiviral effect of IFN-α on HBV replication [50].